Eli Lilly and Company today announced that the U.S. Food and Drug Administration (FDA) has granted approval to Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets) for the treatment of adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback